维普中文期刊产品整合服务
39篇 您的检索式:作者名="Ponticelli F"
    题名 作者 年代 出处 被引量
1Growth inhibition and sensitization to cisplatin hy zoledronic acid in osteosarcoma ceils 显示文摘Benassi MS Chiechi A Ponticelli F 2007Cancer Lett2007,250,2:1
2A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idio- pathic membranous nephropathy 显示文摘Ponticelli C Ahier P Scolari F 1998J Am Soc Neph- rol1998,9,3:1
3A randomized study compa- ring methylprednisolone plus chlorambucil versus methylprednisolo- ne plus cyclophosphamide in idiopathic membranous nephropathy 显示文摘Ponticelli C Ahieri P Scolari F 1998J Am Soe Nephrol1998,9,3:1
4Convenient synthetic approach to 2,4-disubstituted quinazolines显示文摘Ferrini S Ponticelli F Taddei M 2007Org Lett2007,9,1:1
5A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy显示文摘Ponticelli C Altieri P Scolari F 0,,03:1
6Activation of metalloproteinases-2 and-9 by interleukin-1alpha in S100A4-positive liposarcoma cell line:correlation with cell invasiveness显示文摘Pazzaglia L Ponticelli F Magagnoli G 2004Anticancer Res2004,24,2:1
7Kidney and liver involvement in cryoglobulinemia显示文摘Fabrizi F Colucci P Ponticelli C 2002Semin Nephrol2002,22,4:1
8Structural characterization and regiochemical differentiation of alpha-cyano- ethylindole isomers in the gas phase显示文摘GIORGI G PONTICELLI F 2005J Am Soc Mass Spectrom2005,16,3:1
9A randomized studycomparing methylprednisolone plus chlorambucil versusmethylprednisolone plus cyclo-phosphamide in idiopathicmembranous nephropathy显示文摘Ponticelli C Altieri P Scolari F 1998J Am Soc Nephrol1998,9,3:1
10Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells显示文摘Benassi MS Chiechi A Ponticelli F 2007Cancer Lett2007,250,2:1
11Altered expression of urokinase -type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomas显示文摘Benassi MS Ponticelli F Azzoni E 2007Histol Histopathol2007,22,9:1
12A randomized study comparing methylprednisolone plus ehloramhucil versus meth- yl-1 prednisolone plus eyelophosphamide in idiopathic mere- bran,ms nephropathy 显示文摘Ponticelli C Altieri P Scolari F 1998J Am Soe Nephrol1998,9,3:1
13A randomized study compm'ing methylprednisolone plus chlorambucil versus methyl- prednisolone plus cyclophosphamide in idiopathic membranous nephropathy显示文摘Ponticelli C Altieri P Scolari F 1998J Am Soc Nephrol1998,9,3:1
14Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years显示文摘FERRARI C BENASSI S PONTICELLI F 2004Acta Orthop Stand2004,75,:1
15Arandomizedstudy comparing methylprednisolone plus chlorambucil versus methylprednisolone plus plus cyclophosphamide in idiopathic membranous nephropathy显示文摘Ponticelli C Altieri P Scolari F 0,,03:1
16A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophasphamide in idiopathic membranous nephropathy显示文摘Ponticelli C Altieri P Scolari F 1998J Am Soc Nephrol1998,9,3:1
17Altered expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomas 显示文摘Benassi MS Ponticelli F Azzoni E 2007Histol Histopathol2007,22,9:1
18A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy显示文摘Ponticelli C Altieri P Scolari F 1998J Am Soc Nephrol1998,9,3:1
19A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy显示文摘 Altieri P Scolari F 1998J Am Soc Nephrol1998,9,3:1
20Activation of metalloproteinases-2 and-9 by interleukin- 1 alpha in S 100A4-positive liposarcoma cell line: correlation with cell invasiveness 显示文摘Pazzaglia L Ponticelli F Magagnoli G 2004Anticancer Res2004,24,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费